Millennium Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-846,008
Closed -$3.37M 6014
2025
Q4
$3.37M Buy
846,008
+823,555
+3,668% +$3.64M ﹤0.01% 3430
2025
Q3
$84.9K Buy
+22,453
New +$76.2K ﹤0.01% 5741
2025
Q2
Sell
-61,478
Closed -$50.7K 6086
2025
Q1
$50.7K Sell
61,478
-36,271
-37% -$34.5K ﹤0.01% 5536
2024
Q4
$83.1K Buy
97,749
+86,424
+763% +$96.2K ﹤0.01% 5509
2024
Q3
$14K Sell
11,325
-28,983
-72% -$36.3K ﹤0.01% 5834
2024
Q2
$67.3K Sell
40,308
-53,200
-57% -$95.1K ﹤0.01% 5375
2024
Q1
$174K Sell
93,508
-97,793
-51% -$180K ﹤0.01% 5420
2023
Q4
$363K Sell
191,301
-363,445
-66% -$543K ﹤0.01% 4842
2023
Q3
$732K Buy
+554,746
New +$1.22M ﹤0.01% 4404
2023
Q2
Sell
-690,767
Closed -$2.39M 6375
2023
Q1
$2.39M Buy
690,767
+308,125
+81% +$1.49M ﹤0.01% 3265
2022
Q4
$1.6M Buy
382,642
+338,675
+770% +$1.28M ﹤0.01% 3753
2022
Q3
$176K Buy
43,967
+13,080
+42% +$99.2K ﹤0.01% 5731
2022
Q2
$349K Sell
30,887
-150,466
-83% -$1.8M ﹤0.01% 5240
2022
Q1
$2.94M Buy
181,353
+112,374
+163% +$2.88M ﹤0.01% 3517
2021
Q4
$3.27M Buy
68,979
+10,450
+18% +$627K ﹤0.01% 3307
2021
Q3
$4.24M Buy
58,529
+32,669
+126% +$2.36M ﹤0.01% 3055
2021
Q2
$2.17M Sell
25,860
-304,036
-92% -$20.1M ﹤0.01% 3862
2021
Q1
$16M Buy
329,896
+299,397
+982% +$16.2M 0.01% 1296
2020
Q4
$1.44M Buy
30,499
+26,123
+597% +$1.03M ﹤0.01% 3478
2020
Q3
$206 Buy
+4,376
New +$144K ﹤0.01% 4046
2020
Q2
Sell
-17,193
Closed -$224K 4362
2020
Q1
$224K Buy
+17,193
New +$215K ﹤0.01% 3328

Other funds holding NBP

Millennium Management's NBP Position: Q1 2026 in Review

Millennium Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 846,008 shares — an estimated $3.37M sold.

Millennium Management first reported a position in NBP in Q1 2020 and held it in 21 quarters. The position peaked at $16M in Q1 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Millennium Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 846,008 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $3.37M.
  • Millennium Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 21 quarters.
  • Millennium Management's NovaBridge Biosciences American Depositary Shares position peaked at $16M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.